We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
+1.41%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$712M
AUM Growth
+$710M
(+43,807%)
Cap. Flow
-$649M
Cap. Flow
% of AUM
-91.27%
Top 10 Holdings %
Top 10 Hldgs %
6.85%
Holding
408
New
37
Increased
7
Reduced
332
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.58M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$2M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.96M |
| 4 |
Signet Jewelers
SIG
|
+$1.34M |
| 5 |
YHOO
Yahoo Inc
YHOO
|
+$1.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$14.4M |
| 2 |
Microsoft
MSFT
|
+$7.81M |
| 3 |
Apple
AAPL
|
+$6.72M |
| 4 |
Gilead Sciences
GILD
|
+$5.41M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$5.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.08% |
| 2 | Financials | 13.4% |
| 3 | Healthcare | 12.23% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
AtriCure
ATRC
$2.11B
| $629K | 0.09% |
44,488
-76,058
| -63% | -$1.16M |
|
|
VIAB
352
DELISTED
Viacom Inc. Class B
VIAB
| $623K | 0.09% |
+15,015
| New | +$621K |
|
353
Autodesk
ADSK
$52.6B
| $618K | 0.09% |
+11,410
| New | +$660K |
|
354
Alaunos Therapeutics
TCRT
$4.86M
| $616K | 0.09% |
748
-244
| -25% | -$266K |
|
|
PXD
355
DELISTED
Pioneer Natural Resource Co.
PXD
| $612K | 0.09% |
+4,046
| New | +$635K |
|
|
JUNO
356
DELISTED
Juno Therapeutics, Inc.
JUNO
| $606K | 0.09% |
15,776
-14,544
| -48% | -$604K |
|
|
ADAP
357
DELISTED
Adaptimmune Therapeutics
ADAP
| $600K | 0.08% |
73,572
-67,514
| -48% | -$636K |
|
|
QLIK
358
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $600K | 0.08% |
20,274
-66,370
| -77% | -$1.98M |
|
359
Inovio Pharmaceuticals
INO
$69M
| $586K | 0.08% |
5,282
-12,300
| -70% | -$1.49M |
|
360
NXP Semiconductors
NXPI
$60.4B
| $576K | 0.08% |
+7,357
| New | +$631K |
|
361
Sasol
SSL
$7.1B
| $575K | 0.08% |
+21,204
| New | +$623K |
|
362
Interactive Brokers
IBKR
$39.8B
| $572K | 0.08% |
+64,596
| New | +$616K |
|
363
Lazard
LAZ
$4.31B
| $548K | 0.08% |
18,399
-38,981
| -68% | -$1.35M |
|
364
Compugen
CGEN
$228M
| $522K | 0.07% |
+80,494
| New | +$537K |
|
365
ProShares Short VIX Short-Term Futures ETF
SVXY
$206M
| $498K | 0.07% |
+10,148
| New | +$549K |
|
366
Waste Management
WM
$91B
| $495K | 0.07% |
7,466
-3,420
| -31% | -$207K |
|
367
Broadcom
AVGO
$2.04T
| $493K | 0.07% |
31,740
-179,900
| -85% | -$2.74M |
|
368
UGI
UGI
$7.33B
| $483K | 0.07% |
10,672
-5,140
| -33% | -$217K |
|
369
Angi Inc
ANGI
$196M
| $481K | 0.07% |
7,385
-14,879
| -67% | -$1.23M |
|
370
ProShares VIX Short-Term Futures ETF
VIXY
$183M
| $469K | 0.07% |
+32
| New | +$528K |
|
371
Morgan Stanley
MS
$340B
| $225K | 0.03% |
+8,671
| New | +$227K |
|
372
Bank of America
BAC
$442B
| $221K | 0.03% |
+16,645
| New | +$234K |
|
373
Darden Restaurants
DRI
$24.4B
| $202K | 0.03% |
3,193
-31,149
| -91% | -$2.04M |
|
374
Ford
F
$55.7B
| $146K | 0.02% |
+11,613
| New | +$153K |
|
|
S
375
DELISTED
Sprint Corporation
S
| $98K | 0.01% |
21,590
-36,244
| -63% | -$134K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q2 2016 Portfolio in Review
As of Q2 2016, Vident Investment Advisory held 408 positions worth $712M, up 43,807% from $1.62M the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
Vident Investment Advisory withdrew a net $649M in Q2 2016, closing 32 positions and reducing 332 holdings. Its most notable exit was Allergan plc, an estimated $11.2K position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Vident Investment Advisory opened a new position in State Street SPDR S&P 500 ETF Trust worth $9.68M.
- Vident Investment Advisory's largest Q2 2016 buy was State Street SPDR S&P 500 ETF Trust: 46,190 shares worth $9.68M.
- Vident Investment Advisory added most to Meta Platforms (Facebook) in Q2 2016, an estimated $1.05M increase.
- Vident Investment Advisory's biggest Q2 2016 reduction was Amazon, cutting an estimated $14.4M.
- Vident Investment Advisory fully exited Allergan plc in Q2 2016, selling an estimated $11.2K.
- Vident Investment Advisory's ten largest holdings make up 6.9% of its $712M portfolio in Q2 2016.
- Vident Investment Advisory opened 37 new positions and closed 32 in Q2 2016.
- Vident Investment Advisory's portfolio value rose 43,807% quarter-over-quarter to $712M.
Based on Vident Investment Advisory's 13F filing for Q2 2016, filed 12 Aug 2016.